162 related articles for article (PubMed ID: 19294416)
1. Status of HER1 and HER2 in peritoneal, ovarian and colorectal endometriosis and ovarian endometrioid adenocarcinoma.
Uzan C; Darai E; Valent A; Graesslin O; Cortez A; Rouzier R; Vielh P
Virchows Arch; 2009 May; 454(5):525-9. PubMed ID: 19294416
[TBL] [Abstract][Full Text] [Related]
2. Expression of apoptosis-related proteins in peritoneal, ovarian and colorectal endometriosis.
Dufournet C; Uzan C; Fauvet R; Cortez A; Siffroi JP; Daraï E
J Reprod Immunol; 2006 Jun; 70(1-2):151-62. PubMed ID: 16378643
[TBL] [Abstract][Full Text] [Related]
3. Eutopic endometrium and peritoneal, ovarian and colorectal endometriotic tissues express a different profile of nectin-1, -3, -4 and nectin-like molecule 2.
Ballester M; Gonin J; Rodenas A; Bernaudin JF; Rouzier R; Coutant C; Daraï E
Hum Reprod; 2012 Nov; 27(11):3179-86. PubMed ID: 22926846
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis.
Barreta A; Sarian LO; Ferracini AC; Costa LBE; Mazzola PG; de Angelo Andrade L; Derchain S
Hum Pathol; 2019 Mar; 85():72-81. PubMed ID: 30447298
[TBL] [Abstract][Full Text] [Related]
5. Higher frequency of chromosomal aberrations in ovarian endometriosis compared to extragonadal endometriosis: A possible link to endometrioid adenocarcinoma.
Körner M; Burckhardt E; Mazzucchelli L
Mod Pathol; 2006 Dec; 19(12):1615-23. PubMed ID: 16980942
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of HER2 gene status in breast cancer with HER2 protein overexpression].
Zeng X; Liang ZY; Wu SF; Zhou WX; Gao J; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):584-8. PubMed ID: 17134563
[TBL] [Abstract][Full Text] [Related]
7. Genomic imbalance and onco-protein expression of ovarian endometrioid adenocarcinoma arisen in an endometriotic cyst.
Noack F; Schmidt H; Buchweitz O; Malik E; Horny HP
Anticancer Res; 2004; 24(1):151-4. PubMed ID: 15015590
[TBL] [Abstract][Full Text] [Related]
8. Human Epidermal Growth Factor Receptor 2 Overexpression/Amplification in Primary Ovarian Endometrioid Carcinoma.
Bui CM; Oren A; Balzer B; Maluf H; Medeiros F
Appl Immunohistochem Mol Morphol; 2024 May-Jun 01; 32(5):222-228. PubMed ID: 38635473
[TBL] [Abstract][Full Text] [Related]
9. Ovarian carcinomas in endometriosis: an immunohistochemical and comparative genomic hybridization study.
Mhawech P; Kinkel K; Vlastos G; Pelte MF
Int J Gynecol Pathol; 2002 Oct; 21(4):401-6. PubMed ID: 12352189
[TBL] [Abstract][Full Text] [Related]
10. Endometrioid adenocarcinoma arising from colonic endometriosis mimicking primary colonic carcinoma.
Chen KT
Int J Gynecol Pathol; 2002 Jul; 21(3):285-8. PubMed ID: 12068177
[TBL] [Abstract][Full Text] [Related]
11. Identification of oncofetal fibronectin in patients with advanced epithelial ovarian cancer: detection in ascitic fluid and localization to primary sites and metastatic implants.
Menzin AW; Loret de Mola JR; Bilker WB; Wheeler JE; Rubin SC; Feinberg RF
Cancer; 1998 Jan; 82(1):152-8. PubMed ID: 9428492
[TBL] [Abstract][Full Text] [Related]
12. Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patients.
Liang Z; Zeng X; Gao J; Wu S; Wang P; Shi X; Zhang J; Liu T
BMC Cancer; 2008 Dec; 8():363. PubMed ID: 19061514
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor-1 (PAI-1) expression in endometriosis.
Alotaibi FT; Peng B; Klausen C; Lee AF; Abdelkareem AO; Orr NL; Noga H; Bedaiwy MA; Yong PJ
PLoS One; 2019; 14(7):e0219064. PubMed ID: 31315131
[TBL] [Abstract][Full Text] [Related]
14. The dichotomy in the histogenesis of endometriosis-associated ovarian cancer: clear cell-type versus endometrioid-type adenocarcinoma.
Kajihara H; Yamada Y; Shigetomi H; Higashiura Y; Kobayashi H
Int J Gynecol Pathol; 2012 Jul; 31(4):304-12. PubMed ID: 22653342
[TBL] [Abstract][Full Text] [Related]
15. Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation?
Samartzis EP; Samartzis N; Noske A; Fedier A; Caduff R; Dedes KJ; Fink D; Imesch P
Mod Pathol; 2012 Jun; 25(6):885-92. PubMed ID: 22301703
[TBL] [Abstract][Full Text] [Related]
16. Endometrioid ovarian cancer and endometriotic cells exhibit the same alteration in the expression of interleukin-1 receptor II: to a link between endometriosis and endometrioid ovarian cancer.
Keita M; AinMelk Y; Pelmus M; Bessette P; Aris A
J Obstet Gynaecol Res; 2011 Feb; 37(2):99-107. PubMed ID: 21083841
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis.
Nisolle M; Casanas-Roux F; Donnez J
Fertil Steril; 1997 Nov; 68(5):912-9. PubMed ID: 9389825
[TBL] [Abstract][Full Text] [Related]
18. Stromal cells from endometriotic lesions and endometrium from women with endometriosis have reduced decidualization capacity.
Klemmt PA; Carver JG; Kennedy SH; Koninckx PR; Mardon HJ
Fertil Steril; 2006 Mar; 85(3):564-72. PubMed ID: 16500320
[TBL] [Abstract][Full Text] [Related]
19. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
[TBL] [Abstract][Full Text] [Related]
20. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
